Marinus Verwijs, CHIEF TECHNICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 10,600 shares at $25.00 ($265K) on 2024-06-14, disclosed to the SEC on 2024-06-14.
Scheduled sale ($265k) by CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVTE | SELL | 2024-03-20 | $277K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $10K | — | Filing → |
| AVTE | SELL | 2023-05-05 | $16K | — | Filing → |